Evaluation of protocol mandated testing in E4A03, a randomized phase III study of CC-5013 plus dexamethasone versus CC-5013 plus low-dose dexamethasone in multiple myeloma (MM). Phase II study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback